Result of treatment and follow-up in our cases with active ocular toxoplasmosis

Basit Öğe Kaydı
dc.contributor.authorTürkcü F.M.
dc.contributor.authorYüksel H.
dc.contributor.authorŞahin A.
dc.contributor.authorÇinar Y.
dc.contributor.authorCingü K.
dc.contributor.authorŞahin M.
dc.contributor.authorYildirim A.
dc.date.accessioned2024-04-24T18:43:47Z
dc.date.available2024-04-24T18:43:47Z
dc.date.issued2014
dc.departmentDicle Üniversitesien_US
dc.description.abstractPurpose: To evaluate the clinical characteristics, follow-up findings and treatment outcomes of patients diagnosed as active ocular toxoplasmosis (OT) in our clinic. Material and Methods: The data of seventy five active OT patients seen between 2009 and 2012 were analyzed retrospectively. Age, gender, visual acuity, laterality, follow-up findings, treatment modalities, complications, and recurrence rate of the patients were evaluated. Results: Active OT was diagnosed in 75 eyes of 75 patients. The mean age of the patients was 26.3±7.8 years with 47 (62.7%) females and 28 (37.3%) were males. The detected involvement sites were 60% central and 40% peripheral. All the patients had active lesions at the time of application. Contralateral chorioretinal scars were identified in 17.3% of the patients. The mean follow-up was 15.1±10.0 months. Complications were cataract formation in 2 patients, posterior synechiae in 5 patients, vitreous condensation in 2 patients and epiretinal membrane formation in 4 patients. Recurrence rate was 38.7% during follow-up and recurrences were all in the same eye. Conclusion: Ocular toxoplasmosis is the most common infectious uveitis. Although it is a self-limiting disease, treatment and follow-up are very important because of potential reduction in vision caused by serious complications. Early treatment and long term follow-up are essential to prevent to development of sequelae and ensure early detection of complications in patient with active OT.en_US
dc.identifier.endpage54en_US
dc.identifier.issn1300-1256
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-84904308844
dc.identifier.scopusqualityQ4
dc.identifier.startpage50en_US
dc.identifier.urihttps://hdl.handle.net/11468/24378
dc.identifier.volume22en_US
dc.indekslendigikaynakScopus
dc.language.isotren_US
dc.publisherGazi Eye Foundationen_US
dc.relation.ispartofRetina-Vitreus
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectChorioretinitisen_US
dc.subjectToxoplasmosisen_US
dc.titleResult of treatment and follow-up in our cases with active ocular toxoplasmosisen_US
dc.titleResult of treatment and follow-up in our cases with active ocular toxoplasmosis
dc.title.alternativeAktif oküler toksoplazmozisli olgularda takip ve tedavi sonuçlarimizen_US
dc.title.alternativeAktif oküler toksoplazmozisli olgularda takip ve tedavi sonuçlarimiz
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu